These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8420788)

  • 21. Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat.
    Bagdy G; Kalogeras KT
    Brain Res; 1993 May; 611(2):330-2. PubMed ID: 8334526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (+/-)-1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane(DOI) and alpha-methyl-5-HT: 5-HT2 receptor agonistic action on phosphatidylinositol metabolism in the rat fronto-cingulate and entorhinal cortex.
    Edwards E; Ashby CR; Wang RY
    Neuropharmacology; 1992 Jul; 31(7):615-21. PubMed ID: 1407401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of 5-HT1C-receptors suppresses excessive wheel running induced by semi-starvation in the rat.
    Wilckens T; Schweiger U; Pirke KM
    Psychopharmacology (Berl); 1992; 109(1-2):77-84. PubMed ID: 1365675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for involvement of 5-HT2 and 5-HT1C receptors in the behavioral effects of the 5-HT agonist 1-(2,5-dimethoxy-4-iodophenyl aminopropane)-2 (DOI).
    Pranzatelli MR
    Neurosci Lett; 1990 Jul; 115(1):74-80. PubMed ID: 2216059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo.
    Done CJ; Sharp T
    Br J Pharmacol; 1992 Sep; 107(1):240-5. PubMed ID: 1422575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Competitive antagonism by recognized 5-HT2 receptor antagonists at 5-HT1C receptors in pig choroid plexus.
    Sahin-Erdemli I; Schoeffter P; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Aug; 344(2):137-42. PubMed ID: 1944609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-Hydroxytryptamine1C/2 agonists in the thoracic spinal cord: cardiovascular effects and binding sites in the intermediolateral cell column.
    Helke CJ; Thor KB; Phillips ET
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1335-43. PubMed ID: 1762081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological characteristics and regulation of 5-HT receptor-stimulated phosphoinositide hydrolysis in the rat spinal cord.
    Toscano E; Romero G; Oset C; Del Río J
    Gen Pharmacol; 1999 Mar; 32(3):351-8. PubMed ID: 10211591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of the 5-HT1C receptor-mediated behavior by 5-HT2, but not 5-HT1A, receptor activation.
    Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1992; 44(5):427-36. PubMed ID: 1363616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional subsensitivity of 5-HT2A and 5-HT2C receptors mediating hyperthermia following acute and chronic treatment with 5-HT2A/2C receptor antagonists.
    Mazzola-Pomietto P; Aulakh CS; Tolliver T; Murphy DL
    Psychopharmacology (Berl); 1997 Mar; 130(2):144-51. PubMed ID: 9106912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [3H]-Mesulergine labels 5-HT7 sites in rat brain and guinea-pig ileum but not rat jejunum.
    Hemedah M; Coupar IM; Mitchelson FJ
    Br J Pharmacol; 1999 Jan; 126(1):179-88. PubMed ID: 10051134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice.
    Berendsen HH; Broekkamp CL
    Br J Pharmacol; 1990 Nov; 101(3):667-73. PubMed ID: 2150180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of 5-HT(2A) receptor mRNA levels and binding sites in rat frontal cortex by the agonist DOI and the antagonist mianserin.
    Anji A; Kumari M; Sullivan Hanley NR; Bryan GL; Hensler JG
    Neuropharmacology; 2000 Aug; 39(11):1996-2005. PubMed ID: 10963743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of prolactin secretion via 5-HT1c/2 receptors.
    Rittenhouse PA; Levy AD; Li Q; Bethea CL; Van de Kar LD
    Endocrinology; 1993 Aug; 133(2):661-7. PubMed ID: 8344205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons.
    Sheldon PW; Aghajanian GK
    Synapse; 1991 Nov; 9(3):208-18. PubMed ID: 1776132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-HT2/5-HT1C receptor-mediated facilitatory action on unit activity of ventral horn cells in rat spinal cord slices.
    Yamazaki J; Fukuda H; Nagao T; Ono H
    Eur J Pharmacol; 1992 Sep; 220(2-3):237-42. PubMed ID: 1358651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperthermia induced by m-trifluoromethylphenylpiperazine (TFMPP) or m-chlorophenylpiperazine (m-CPP) in heat-adapted rats.
    Kłodzińska A; Chojnacka-Wójcik E
    Psychopharmacology (Berl); 1992; 109(4):466-72. PubMed ID: 1365864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.